Literature DB >> 15720328

The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management.

W Marston Linehan1, Robert L Grubb, Jonathan A Coleman, Berton Zbar, McClellan M Walther.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720328     DOI: 10.1111/j.1464-410X.2005.05189.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  12 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Activation of G protein coupled estrogen receptor (GPER) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals.

Authors:  Bao-Zhang Guan; Rui-Ling Yan; Jian-Wei Huang; Fo-Lan Li; Ying-Xue Zhong; Yu Chen; Fan-Na Liu; Bo Hu; Si-Bo Huang; Liang-Hong Yin
Journal:  Cell Adh Migr       Date:  2018-01-29       Impact factor: 3.405

3.  Automated noninvasive classification of renal cancer on multiphase CT.

Authors:  Marius George Linguraru; Shijun Wang; Furhawn Shah; Rabindra Gautam; James Peterson; W Marston Linehan; Ronald M Summers
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

4.  Renal Tumor Quantification and Classification in Contrast-Enhanced Abdominal CT.

Authors:  Marius George Linguraru; Jianhua Yao; Rabindra Gautam; James Peterson; Zhixi Li; W Marston Linehan; Ronald M Summers
Journal:  Pattern Recognit       Date:  2009-06-01       Impact factor: 7.740

Review 5.  [Value of targeted therapies for renal cell cancer].

Authors:  A S Merseburger; M A Kuczyk
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

6.  A human bone morphogenetic protein antagonist is down-regulated in renal cancer.

Authors:  Kimberly Rose Blish; Wei Wang; Mark C Willingham; Wei Du; Charles E Birse; Surekha R Krishnan; Julie C Brown; Gregory A Hawkins; A Julian Garvin; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Mol Biol Cell       Date:  2007-11-21       Impact factor: 4.138

7.  Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney.

Authors:  Rameen Beroukhim; Jean-Philippe Brunet; Arianna Di Napoli; Kirsten D Mertz; Apryle Seeley; Maira M Pires; David Linhart; Robert A Worrell; Holger Moch; Mark A Rubin; William R Sellers; Matthew Meyerson; W Marston Linehan; William G Kaelin; Sabina Signoretti
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

8.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

9.  Sunitinib for advanced renal cell cancer.

Authors:  Chris Coppin
Journal:  Biologics       Date:  2008-03

Review 10.  Targeted therapy for advanced renal cell carcinoma.

Authors:  C Coppin; L Le; F Porzsolt; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.